Pembrolizumab

Immunoglobulin G4, anti-(human protein PDCD1 (programmed cell death 1)) (human-Mus musculus monoclonal heavy chain), disulfide with human-Mus musculus monoclonal light chain, dimer

Stoffgruppe

Antineoplastisches Mittel (Checkpoint-Inhibitor)